LBLF-01

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameLBLF-01
Drug Alias NameLBLF-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsHepatocyte growth factor receptor inhibitors
TargetsVascular endothelial growth factor receptor 2Hepatocyte growth factor receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Neptunus Bioengineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Neptunus Bioengineering Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A